<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">501749</article-id><article-id pub-id-type="doi">10.17816/KMJ501749</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Experimental medicine</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Экспериментальная медицина</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Evaluation of angiogenesis and microvascular remodeling in the subventricular zone of the brain of mice with experimental Alzheimer’s disease</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка ангиогенеза и ремоделирования микрососудов в субвентрикулярной зоне головного мозга мышей при экспериментальной болезни Альцгеймера</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1284-6711</contrib-id><contrib-id contrib-id-type="scopus">57204197597</contrib-id><contrib-id contrib-id-type="researcherid">I-1075-2018</contrib-id><contrib-id contrib-id-type="spin">7276-8713</contrib-id><name-alternatives><name xml:lang="en"><surname>Averchuk</surname><given-names>Anton S.</given-names></name><name xml:lang="ru"><surname>Аверчук</surname><given-names>Антон Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.), Assoc. Prof., Researcher, Laboratory of Neurobiology and Tissue Engineering, Brain Science Institute</p></bio><bio xml:lang="ru"><p>канд. биол. наук, доц., н.с. лаборатории нейробиологии и тканевой инженерии, Институт мозга</p></bio><email>antonaverchuk@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0700-4912</contrib-id><name-alternatives><name xml:lang="en"><surname>Ryazanova</surname><given-names>Maria V.</given-names></name><name xml:lang="ru"><surname>Рязанова</surname><given-names>Мария Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Postgrad. Stud., Laboratory of Neurobiology and Tissue Engineering, Brain Science Institute</p></bio><bio xml:lang="ru"><p>асп., лаб. нейробиологии и тканевой инженерии, Институт мозга</p></bio><email>mashenka.ryazanova@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8689-0934</contrib-id><name-alternatives><name xml:lang="en"><surname>Stavrovskaya</surname><given-names>Alla V.</given-names></name><name xml:lang="ru"><surname>Ставровская</surname><given-names>Алла Вадимовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.), Head, Laboratory of Experimental Pathology of the Nervous System, Brain Science Institute</p></bio><bio xml:lang="ru"><p>канд. биол. наук, руководитель, лаборатория экспериментальной патологии нервной системы, Институт мозга</p></bio><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3905-1928</contrib-id><name-alternatives><name xml:lang="en"><surname>Novikova</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Новикова</surname><given-names>Светлана Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Junior Researcher, Laboratory of Experimental Pathology of the Nervous System, Brain Science Institute</p></bio><bio xml:lang="ru"><p>м.н.с., лаборатория нейробиологии и тканевой инженерии, Институт мозга</p></bio><email>levik_82@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4012-6348</contrib-id><name-alternatives><name xml:lang="en"><surname>Salmina</surname><given-names>Alla B.</given-names></name><name xml:lang="ru"><surname>Салмина</surname><given-names>Алла Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., D. Sci. (Med), Prof., Chief Researcher, Head, Laboratory of Experimental Pathology of the Nervous System, Brain Science Institute</p></bio><bio xml:lang="ru"><p>докт. мед. наук, проф., главный научный сотрудник, руководитель, лаборатория нейробиологии и тканевой инженерии, Институт мозга</p></bio><email>allasalmina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">Научный центр неврологии</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-03-11" publication-format="electronic"><day>11</day><month>03</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-04-01" publication-format="electronic"><day>01</day><month>04</month><year>2024</year></pub-date><volume>105</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>231</fpage><lpage>239</lpage><history><date date-type="received" iso-8601-date="2023-06-19"><day>19</day><month>06</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-01-25"><day>25</day><month>01</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2027-04-01"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/501749">https://kazanmedjournal.ru/kazanmedj/article/view/501749</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Under the influence of external factors (learning), processes of microvasculature remodeling occur in the neurogenic niche to meet the metabolic needs of activated cells. However, it remains unclear how these mechanisms of brain plasticity are disrupted during neurodegeneration.</p> <p><bold>AIM:</bold> To study the expression features of markers of angiogenesis and microvascular remodeling in the subventricular zone of the brain during training of animals, including against the background of the development of Alzheimer’s-type neurodegeneration in them.</p> <p><bold>MATERIAL AND METHODS: </bold>The studies were carried out on C57BL/6 mice at the age of 8 months. Modeling of Alzheimer’s disease was carried out by intrahippocampal injection of 2 μl of a 1 mM solution of β-amyloid Aβ25-35. To assess cognitive deficits, a conditioned passive avoidance test using an aversive stimulus was used. The expression of LC3B, ZO1, VEGFR2, VEGFR3, CD146, ICAM2, Dll4, Tie2 in the subventricular zone per 100 DAPI-positive cells was assessed. The test results were processed using one-way ANOVA and Fisher's test, the Mann–Whitney U test, the results were considered significant at p &lt;0.05.</p> <p><bold>RESULTS:</bold> On the 9th day after the administration of β-amyloid, before the application of the aversive stimulus, an increase in the expression level of LC3 (7.95±5.83%, p=0.045), CD146 (18.35±0.01%, p=0.045) was recorded, as well as VEGFR3 (17.13±5.05%, p=0.045), which continued to increase after the presentation of the stimulus (26.61±0.01%, p=0.045). By the beginning of registration of cognitive impairment (38th day of the experiment), the expression level of VEGFR2 (20.61±2.8%, p=0.045) and ICAM2 (126.61±41.28%, p=0.045) increased, the content of Dll4 (29.66±8.72%, p=0.045) and Tie2 (36.39±7.8%, p=0.045) decreased in animals with experimental Alzheimer’s disease.</p> <p><bold>CONCLUSION:</bold> An aversive stimulus stimulates microvascular remodeling mechanisms in the subventricular zone of the animal’s brain, but when exposed to β-amyloid, these processes are significantly disrupted.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> Под воздействием внешних факторов (обучение) в нейрогенной нише происходят процессы ремоделирования микроциркуляторного русла для обеспечения метаболических потребностей активированных клеток, но каким образом эти механизмы пластичности мозга нарушаются при нейродегенерации, остаётся невыясненным.</p> <p><bold>Цель.</bold> Изучить особенности экспрессии маркёров ангиогенеза и ремоделирования микрососудов в субвентрикулярной зоне головного мозга при обучении животных, в том числе на фоне развития у них нейродегенерации альцгеймеровского типа.</p> <p><bold>Материал и методы. </bold>Исследования проводили на мышах линии C57BL/6 в возрасте 8 мес. Моделирование болезни Альцгеймера осуществляли интрагиппокампальным введением 2 мкл 1 мМ раствора β-амилоида Аβ25-35. Для оценки когнитивного дефицита использовали тест условно-пассивного избегания с применением аверсивного раздражителя. Оценивали экспрессию LC3B, ZO1, VEGFR2, VEGFR3, CD146, ICAM2, Dll4, Tie2 в субвентрикулярной зоне в расчёте на 100 DAPI-позитивных клеток. Результаты тестов обрабатывали с использованием однофакторного анализа ANOVA и теста Фишера, критерия U-теста Манна–Уитни, результаты считали значимыми при p &lt;0,05.</p> <p><bold>Результаты. </bold>На 9-е сутки после введения β-амилоида, до применения аверсивного стимула, зафиксировано увеличение уровня экспрессии LC3 (7,95±5,83%, р=0,045), CD146 (18,35±0,01%, р=0,045), а также VEGFR3 (17,13±5,05%, р=0,045), который продолжает возрастать после предъявления раздражителя (26,61±0,01%, р=0,045). К началу регистрации когнитивных нарушений (38-е сутки эксперимента) повышается уровень экспрессии VEGFR2 (20,61±2,8%, р=0,045) и ICAM2 (126,61±41,28%, р=0,045), снижается содержание Dll4 (29,66±8,72%, р=0,045) и Tie2 (36,39±7,8%, р=0,045) у животных с экспериментальной болезнью Альцгеймера.</p> <p><bold>Вывод.</bold> Аверсивный раздражитель стимулирует механизмы ремоделирования микрососудов в субвентрикулярной зоне головного мозга животного, но при воздействии β-амилоида эти процессы существенно нарушаются.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Alzheimer’s disease</kwd><kwd>angiogenesis</kwd><kwd>neurogenic niche</kwd><kwd>subventricular zone</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Альцгеймера</kwd><kwd>ангиогенез</kwd><kwd>нейрогенная ниша</kwd><kwd>субвентрикулярная зона</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Исследование выполнено при поддержке РНФ (грант №22-15-00126; https://rscf.ru/project/221500126)</institution></institution-wrap><institution-wrap><institution xml:lang="en">The study was supported by the Russian Science Foundation (grant No. 22-15-00126; https://rscf.ru/project/221500126).</institution></institution-wrap></funding-source><award-id>22-15-00126</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bogorad MI, DeStefano JG, Linville RM, Wong AD, Searson PC. Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels. J Cereb Blood Flow Metab. 2019;39(8):1413–1432. DOI: 10.1177/0271678X19855875.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ryazanova MV, Averchuk AS, Novikova SV, Salmina AB. Molecular mechanisms of angiogenesis: Brain is in the focus. Opera Medica et Physiologica. 2022;9(2):54–72. DOI: 10.24412/2500-2295-2022-2-54-72.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Tregub PP, Averchuk AS, Baranich TI, Ryazanova MV, Salmina AB. Physiological and pathological remodeling of cerebral microvessels. Int J Mol Sci. 2022;23(20):12683. DOI: 10.3390/ijms232012683.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cutler RR, Kokovay E. Rejuvenating subventricular zone neurogenesis in the aging brain. Curr Opin Pharmacol. 2020;50:1–8. DOI: 10.1016/j.coph.2019.10.005.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Lin R, Cai J, Nathan C, Wei X, Schleidt S, Rosenwasser R, Iacovitti L. Neurogenesis is enhanced by stroke in multiple new stem cell niches along the ventricular system at sites of high BBB permeability. Neurobiol Dis. 2015;74:229–239. DOI: 10.1016/j.nbd.2014.11.016.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Steinman J, Sun HS, Feng ZP. Microvascular alterations in Alzheimer's disease. Front Cell Neurosci. 2021;14:618986. DOI: 10.3389/fncel.2020.618986.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dong X, Wang YS, Dou GR, Hou HY, Shi YY, Zhang R, Ma K, Wu L, Yao LB, Cai Y, Zhang J. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLoS One. 2011;6(4):e18481. DOI: 10.1371/journal.pone.0018481.</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Averchuk AS, Ryazanova MV, Baranich TI, Stavrovskaya AV, Rozanova NA, Novikova SV, Salmina AB. The neurotoxic effect of beta-amyloid is accompanied with changes in the mitochondrial dynamics and autophagy in neurons and brain endothelial cells in the experimental model of Alzheimer’s disease. Bulletin Exper Biol Med. 2023;175(3):291–297. (In Russ.) DOI: 10.47056/0365-9615-2023-175-3-291-297.</mixed-citation><mixed-citation xml:lang="ru">Аверчук А.С., Рязанова М.В., Баранич Т.И., Ставровская А.В., Розанова Н.А., Новикова С.В., Салмина А.Б. Нейротоксическое действие бета-амилоида сопровождается изменением митохондриальной динамики и аутофагии нейронов и клеток церебрального эндотелия в экспериментальной модели болезни Альцгеймера. Бюллетень экспериментальной биологии и медицины. 2023;175(3):291–297. DOI: 10.47056/0365-9615-2023-175-3-291-297.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><mixed-citation>Amsellem V, Dryden NH, Martinelli R, Gavins F, Almagro LO, Birdsey GM, Haskard DO, Mason JC, Turowski P, Randi AM. ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling. Cell Commun Signal. 2014;12:12. DOI: 10.1186/1478-811X-12-12.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Pang D, Wang L, Dong J, Lai X, Huang Q, Milner R, Li L. Integrin α5β1-Ang1/Tie2 receptor cross-talk regulates brain endothelial cell responses following cerebral ischemia. Exp Mol Med. 2018;50(9):1–12. DOI: 10.1038/s12276-018-0145-7.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Wang X, Bove AM, Simone G, Ma B. Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell Dev Biol. 2020;8:599281. DOI: 10.3389/fcell.2020.599281.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Heinolainen K, Karaman S, D'Amico G et al. VEGFR3 modulates vascular permeability by controlling VEGF/VEGFR2 signaling. Circ Res. 2017;120(9):1414–1425. DOI: 10.1161/CIRCRESAHA.116.310477.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Moritz F, Schniering J, Distler JHW et al. Tie2 as a novel key factor of microangiopathy in systemic sclerosis. Arthritis Res Ther. 2017;19(1):105. DOI: 10.1186/s13075-017-1304-2.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>González-Salinas S, Medina AC, Alvarado-Ortiz E, Antaramian A, Quirarte GL, Prado-Alcalá RA. Retrieval of inhibitory avoidance memory induces differential transcription of arc in striatum, hippocampus, and amygdala. Neuroscience. 2018;382:48–58. DOI: 10.1016/j.neuroscience.2018.04.031.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lobov I, Mikhailova N. The role of Dll4/notch signaling in normal and pathological ocular angiogenesis: Dll4 controls blood vessel sprouting and vessel remodeling in normal and pathological conditions. J Ophthalmol. 2018;2018:3565292. DOI: 10.1155/2018/3565292.</mixed-citation></ref></ref-list></back></article>
